Transient global amnesia-like epdisode due to mistaken intake of zolpidem: Drug safety concern in the elderly

Journal of Patient Safety

Volumn 5, Issue 1, 2009, Pages 32-34

  Tsai, Ming Yen ^a   Tsai, Meng Han ^a   Yang, Shih Chung ^a   Tseng, Yu Lung ^a   Chuang, Yao Chung ^a,b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Amnesia; Elderly; Hypnotics; Medication use safety; Zolpidem

Indexed keywords

HYPNOTIC SEDATIVE AGENT; PYRIDINE DERIVATIVE; ZOLPIDEM;

AGED; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; DRUG TOXICITY; FEMALE; HUMAN; MEDICATION ERROR; SELF MEDICATION; TRANSIENT GLOBAL AMNESIA;

AGED; AMNESIA, TRANSIENT GLOBAL; DRUG TOXICITY; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MEDICATION ERRORS; PYRIDINES; SELF MEDICATION;

EID: 68349144873     PISSN: 15498417     EISSN: 15498425     Source Type: Journal    
DOI: 10.1097/PTS.0b013e3181990d62     Document Type: Article

References (19)

1. Quinette P, Guillery-Girard B, Dayan J, et al. What does transient global amnesia really mean? Review of the literature and thorough study of 142 cases. Brain. 2006;129(Pt 7):1640-1658.
2. Sander K, Sander D. New insights into transient global amnesia: recent imaging and clinical findings. Lancet Neurol. 2005;4:437-444.
3. Lewis SL. Aetiology of transient global amnesia. Lancet. 1998;352:397-399.
4. Sandyk R. Transient global amnesia induced by lorazepam. Clin Neuropharmacol. 1985;8:297-298.
5. Vogel G. Clinical uses and advantages of low doses of benzodiazepine hypnotics. J Clin Psychiatry. 1992;53(suppl):19-22.
6. Canaday BR. Amnesia possibly associated with zolpidem administration. Pharmacotherapy. 1996;16:687-689.
7. Holm KJ, Goa KL. Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia. Drugs. 2000;59:865-889.
8. Bain KT. Management of chronic insomnia in elderly persons. Am J Geriatr Pharmacother. 2006;4:168-192.
9. Swainston Harrison T, Keating GM. Zolpidem: a review of its use in the management of insomnia. CNS Drugs. 2005;19:65-89.
10. Morgenthaler TI, Silber MH. Amnestic sleep-related eating disorder associated with zolpidem. Sleep Med. 2002;3:323-327.
11. Najjar M. Zolpidem and amnestic sleep related eating disorder. J Clin Sleep Med. 2007;3:637-638.
12. Tsai MJ, Tsai YH, Huang YB. Compulsive activity and anterograde amnesia after zolpidem use. Clin Toxicol (Phila). 2007;45:179-181.
13. van Puijenbroek EP, Egberts AC, Krom HJ. Visual hallucinations and amnesia associated with the use of zolpidem. Int J Clin Pharmacol Ther. 1996;34:318.
14. Huang WF, Lai IC. Patterns of sleep-related medications prescribed to elderly outpatients with insomnia in Taiwan. Drugs Aging. 2005;22: 957-965.
15. Huang WF, Lai IC. Potentially inappropriate prescribing for insomnia in elderly outpatients in Taiwan. Int J Clin Pharmacol Ther. 2006;44: 335-342.
16. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA. 1995;274:29-34.
17. Curry LC, Walker C, Hogstel MO, et al. Teaching older adults to self-manage medications: preventing adverse drug reactions. J Gerontol Nurs. 2005;31:32-42.
18. Thompson CA. USP says thousands of drug names look or sound alike. Am J Health Syst Pharm. 2008;65:386-388.
19. Lessard S, DeYoung J, Vazzana N. Medication discrepancies affecting senior patients at hospital admission. Am J Health Syst Pharm. 2006:63:740-743.